Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 829

1.

Acute antidepressant response to fluoxetine and sertraline in psychiatric outpatients with psychomotor agitation.

Lane MF.

Int J Psychiatry Clin Pract. 2001;5(2):103-9. doi: 10.1080/136515001300374830.

PMID:
24931783
2.

Clinical consequences of initial duloxetine dosing strategies: Comparison of 30 and 60 mg QD starting doses.

Dunner DL, Wohlreich MM, Mallinckrodt CH, Watkin JG, Fava M.

Curr Ther Res Clin Exp. 2005 Nov;66(6):522-40. doi: 10.1016/j.curtheres.2005.12.003.

3.

Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression [Internet].

Gartlehner G, Hansen RA, Thieda P, DeVeaugh-Geiss AM, Gaynes BN, Krebs EE, Lux LJ, Morgan LC, Shumate JA, Monroe LG, Lohr KN.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Jan.

4.

A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression.

Olie J, Gunn K, Katz E.

Eur Psychiatry. 1997;12(1):34-41. doi: 10.1016/S0924-9338(97)86377-8.

PMID:
19698503
5.

WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.

Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001851. Review.

PMID:
17636689
6.

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M.

Am J Psychiatry. 2006 Nov;163(11):1905-17.

PMID:
17074942
7.

A simple and valid tool distinguished efficacy from effectiveness studies.

Gartlehner G, Hansen RA, Nissman D, Lohr KN, Carey TS.

J Clin Epidemiol. 2006 Oct;59(10):1040-8. Epub 2006 Aug 4.

PMID:
16980143
8.

Medication augmentation after the failure of SSRIs for depression.

Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ; STAR*D Study Team.

N Engl J Med. 2006 Mar 23;354(12):1243-52.

9.

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M; STAR*D Study Team.

N Engl J Med. 2006 Mar 23;354(12):1231-42.

10.

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ; CONSORT Group.

JAMA. 2006 Mar 8;295(10):1152-60. Erratum in: JAMA. 2006 Oct 18;296(15):1842.

PMID:
16522836
11.

Patient-perceived satisfactory improvement (PPSI): interpreting meaningful change in pain from the patient's perspective.

ten Klooster PM, Drossaers-Bakker KW, Taal E, van de Laar MA.

Pain. 2006 Mar;121(1-2):151-7. Epub 2006 Feb 10.

PMID:
16472915
12.

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force.

Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Sch√ľnemann H.

Chest. 2006 Jan;129(1):174-81. Review.

PMID:
16424429
13.

Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies.

Clayton AH, Stewart RS, Fayyad R, Clary CM.

Arch Womens Ment Health. 2006 May;9(3):151-7. Epub 2005 Nov 15.

PMID:
16292466
14.

Antidepressant and statin interactions: a review and case report of simvastatin and nefazodone-induced rhabdomyolysis and transaminitis.

Karnik NS, Maldonado JR.

Psychosomatics. 2005 Nov-Dec;46(6):565-8. Review. No abstract available.

PMID:
16288136
15.

Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL.

Modell JG, Rosenthal NE, Harriett AE, Krishen A, Asgharian A, Foster VJ, Metz A, Rockett CB, Wightman DS.

Biol Psychiatry. 2005 Oct 15;58(8):658-67.

PMID:
16271314
16.

Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder.

Perahia DG, Kajdasz DK, Desaiah D, Haddad PM.

J Affect Disord. 2005 Dec;89(1-3):207-12. Epub 2005 Nov 2.

PMID:
16266753
17.

Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.

Sir A, D'Souza RF, Uguz S, George T, Vahip S, Hopwood M, Martin AJ, Lam W, Burt T.

J Clin Psychiatry. 2005 Oct;66(10):1312-20.

PMID:
16259546
18.

Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis.

Roy-Byrne PP, Perera P, Pitts CD, Christi JA.

J Clin Psychiatry. 2005 Oct;66(10):1228-33.

PMID:
16259535
19.
20.

Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive disorder treated with fluoxetine.

Cassano P, Soares CN, Cusin C, Mascarini A, Cohen LS, Fava M.

Psychother Psychosom. 2005;74(6):362-5.

PMID:
16244512

Supplemental Content

Support Center